We show that this AMPK-mediated metabolic adaptation is executed in part through the regulation of DNA methylation at key metabolic loci, offering potential pharmacologic targets to modulate Treg cell function in disease, including in severe lung injury and cancer. The gene discussed is PRKAA1; the disease is cancer.